Innovation Success: UM-backed tech promises early diagnosis of chronic kidney disease
Chronic kidney disease (CKD) affects close to a billion people globally, often leading to organ failure due in part to the current high cost and complexity of lab tests.
The UM-affiliated startup AssureCKD is creating rapid and affordable lab-on-a-chip technology called MATLOC, that could be administered anywhere in the world at a patient’s point-of-care. This technology represents more than a decade of research by a UM inventor team led by Dr. Claudio Rigatto and Dr. Francis Lin.